MEI Pharma [thank you Novogen] in the US have partnered up with...

First 13 Last

Share
Profile

Follow
LadyLisbon

18 Posts.

22/08/17

14:34

Post #: 26664288
Share

Originally posted by Pbnewby ↑

How did this get missed from the 15th of August ( 1 week ago):

https://biotechdispatch.com.au/news/winning-one-part-of-the-drug-development-process

"Dr Garner says his focus has been to evolve the company away from its traditional model........"

".....he says Novogen has tried to think about its business in a different way, looking to "win" one part of the process, such as late stage clinical development to phase 2...."

"We want to identify drugs in large pharmaceutical companies where some investment has already been made. We can take it into the next stage and then partner to commercialise. I suppose we're really looking to own drugs for 3 to 6 years. The opportunity exists because large companies tend to produce more intellectual property than they can actually commercialise"

"Dr Garner says Novogen's interest in GDC-0084 did result in Genentech taking another look at the molecule. He says it is even possible the company, which is wholly owned by Roche, could license it back in the future."

Expand

MEI Pharma [thank you Novogen] in the US have partnered up with the Swiss Helsinn Group which means a trade-off has been made between potential royalty stream and making immediate finance available for advancing clinical trials; at the moment both parties are happy with the arrangement.

Something that the current version of Novogen could consider?

https://www.helsinn.com/our-business/partnerships/current-partnership/

NRT Price at posting: 4.2¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

TLX

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

AUG

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

RNU

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

TX3

Canadian fieldwork yields multiple pegmatites for Trinex

There are more pages in this discussion • 39 more messages in this thread...

First 13 Last

Add KZA (ASX) to my watchlist

MEI Pharma [thank you Novogen] in the US have partnered up with...

Top Stories

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug

Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree

Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some

Canadian fieldwork yields multiple pegmatites for Trinex

Featured News